HONA — Honeywell Aerospace Inc

The tape reflects post-spin indigestion, not a demand problem. HONA began regular-way trading June 29, 2026 and has been hit by two things: mechanical post-spin selling (holders who do not want a pure-play, plus ESG funds with defense-exclusion mandates against its 30-35% defense/space mix) and the August 5, 2026 Q2 print, where management cut full-year 2026 sales-growth and earnings guidance even though revenue rose 5% and backlog grew 9% YoY to $18.2B. Headline Q2 numbers looked awful — EPS of $0.78 vs $2.66 a year earlier, operating margin of 12.8% vs 23.6%. Offsetting signals the market is mostly ignoring: Director Craig Arnold bought ~$1M of stock on the open market in early September 2026, RBC is Outperform with a $300 target, and consensus sits at $222 (17 analysts, Buy rating). As of 2026-09-13 the price action is clearly bearish while the 12-month sell-side view is constructive — that gap is the whole story.

Revenue is not the problem: Q1'25 $4.074B to Q1'26 $4.352B (+6.8%) and Q2'25 $4.289B to Q2'26 $4.522B (+5.4%), with sequential growth in both periods. Profitability is the problem, and it is inflecting down hard. Operating income fell from $1,014M in Q2'25 to $578M in Q2'26 (-43%) and operating margin collapsed from 23.6% to 12.8%; Q1'26 margin was 18.7% vs 24.3% in Q1'25. Net income fell from $844M to $246M and diluted EPS from $2.66 to $0.78. Critically, margin fell sequentially from 18.7% in Q1'26 to 12.8% in Q2'26 — the first full standalone quarter was worse, not better. That pattern points to transition cost (separation expense, newly standalone corporate overhead, and interest on $15.85B of long-term debt) rather than demand destruction. Cash generation is far healthier than EPS implies: Q2'26 operating cash flow of $571M and FCF of $448M versus Q1'26 OCF of -$225M and FCF of -$362M, with an accruals ratio of -1.68% (cash running ahead of reported income, the conservative pattern). Bottom line: revenue stable-to-modestly-accelerating, margins structurally reset lower as a standalone entity but plausibly at a trough, and no evidence of a demand-driven cycle rollover.

As of 2026-09-13 the headline multiples are misleading. The TTM P/E of 66.8x and P/S of 5.65x are calculated on a two-quarter 'TTM' — H1 2026 revenue of $8.874B and H1 2026 EPS of $2.367 ($0.78 + $1.59), i.e. a half-year of spin-distorted results, not a trailing year. On forward numbers the picture flips: applying next-FY consensus EPS of $7.89 to the $158.26 price gives ~20.1x, versus a 5-year average P/E of 26.68x; annualized revenue of ~$18B gives ~2.8x sales versus a 5-year average P/S of 4.11x. The PEG of 4.09 is similarly distorted by depressed trailing EPS. So HONA is expensive on distorted trailing data and modestly cheap on forward estimates — the deterministic model's 'Rich vs. its own history' tag is an artifact of the half-year TTM and should be discounted. The genuine caveat is that the $7.89 forward number is unproven and rests on a margin recovery that has not yet appeared.

The market is pricing a messy transition, not a broken franchise. At $158.26 on 2026-09-13 you pay ~20x a next-FY EPS estimate of $7.89 that is ~3.3x the trailing half-year EPS of $2.367 — the stock is explicitly betting on a large step-up in earnings power as separation costs roll off and the $18.2B backlog converts into revenue. That is either the setup or the trap. If the Q3 print (late Oct/early Nov 2026) shows sequential margin recovery and supply-chain healing, the multiple re-rates toward the low-to-mid 20s and the sell-side targets ($222 consensus, $235 recent average, $300 RBC high) stop looking aggressive. If margins stay stuck near 13% without a one-time explanation, the forward estimate gets cut and there is very little earnings support beneath the price.

As of 2026-09-13, RSI(14) stood at 42.8 — soft, but not oversold, with no capitulation signal. The stock sat 1.03% below its 20-day SMA and 15.06% below its 50-day SMA; there is no 200-day average yet because regular-way trading only began June 29, 2026. The one-week return was -1.71% and the one-month return -5.69%, with price near the bottom of the $149.19-$297.50 52-week band and no established long-term support reference. Read: a downtrending but not-yet-washed-out chart with weak intermediate momentum. Entry implication: there is no urgency — wait for either a reclaim of the 50-day (confirming post-spin selling is exhausted) or an RSI push below 30 with a retest of the $149 low, rather than buying into a -15% gap with RSI in the mid-40s.

• Commercial aerospace upcycle: elevated global flight hours and an aging fleet keep aftermarket MRO demand structurally strong, and aftermarket is HONA's highest-margin, most recurring revenue.
• Sub-tier supply chain fragility across aerospace: even with an $18.2B backlog (up 9% YoY), the sector cannot convert demand into deliveries, and HONA has invested over $1B in its supply base since late 2023 with results still lagging.
• Defense and space spending tailwinds (roughly 30-35% of revenue) from elevated geopolitical budgets, partially offset by mechanical selling from ESG funds with strict defense-exclusion mandates.
• Interest rates: affect the discount rate on long-duration industrial cash flows and, more concretely, the cost of servicing and eventually refinancing $15.85B of long-term debt sitting on a balance sheet with negative $5.70B stockholders' equity.
• Post-spin index inclusion and forced-flow dynamics: initial exclusion/rebalancing drove selling into the June 2026 separation, and eventual index inclusion could reverse that flow.

• Q3 2026 earnings (late October or early November 2026) — the single most important checkpoint, testing whether supply-chain investment is converting backlog into revenue and whether operating margin recovers sequentially off the 12.8% Q2 trough.
• Evidence of sub-tier supplier healing and improved aftermarket throughput, which would directly unlock the $18.2B backlog and support the ~$7.89 forward EPS estimate.
• Roll-off of one-time separation costs and clarity on a true standalone cost structure, giving a cleaner earnings base and potentially allowing management to reset guidance higher.
• Continued large-fleet content wins (IndiGo, United) and further backlog growth, reinforcing the durability of the aftermarket franchise.
• Fresh analyst initiations and price targets (17 analysts currently, consensus Buy, $222 PT) plus any index inclusion, both of which could shift the post-spin flow picture favorably.

• Supply-chain bottlenecks persist, backlog conversion slips again, and management is forced into a second guidance cut — the clearest path to a lower stock.
• The margin structure may not be as repairable as assumed: Q2'26 operating margin of 12.8% versus 23.6% a year earlier could reflect a permanently heavier standalone cost base rather than one-time separation costs, in which case the $7.89 forward EPS is far too high.
• Balance sheet fragility: negative stockholders' equity of -$5.70B, $15.85B of long-term debt, a current ratio of 1.53 and a quick ratio of 0.83 limit flexibility and make the company rate-sensitive.
• Estimate and multiple risk are stacked: a ~20x forward P/E resting on an FY2027 EPS figure roughly 3.3x trailing half-year EPS means any downward revision hits price and multiple simultaneously.
• Technical and flow risk: with no 200-day moving average yet and price 15.06% below the 50-day SMA on 2026-09-13, there is no reliable support anchor, and post-spin/ESG-driven selling pressure can persist independent of fundamentals.
• Sentiment/screening risk: the headline 66.8x TTM P/E and negative price-to-book of -8.8x keep the stock off value screens and can sustain a valuation overhang that has nothing to do with the underlying business.

HONA is a genuinely high-quality aerospace franchise — 36.2% gross margin, 22.5% ROIC, a heavily aftermarket-weighted revenue mix, and an $18.2B backlog up 9% YoY — whose trailing numbers were wrecked by the mechanics of a June 2026 spin-off rather than by any demand problem. But 'temporarily wrecked' is still a hypothesis: the 12.8% Q2 operating margin has not been reconciled to a clean standalone level, leverage is heavy, and another guidance cut is a live possibility before Q3. At $158.26 on 2026-09-13 the ~20x forward multiple is undemanding enough to justify building a position for a patient investor, but I would not chase the stock before the Q3 print, and the -15% gap to the 50-day SMA says the market has not finished repricing the spin. Direct answer: interesting, not yet actionable — watchlist, not buy.

Forward P/E on next-FY consensus EPS: 23.0x (a deliberate discount to both the 26.68x 5-year average P/E and the aerospace aftermarket pure-play peer set, reflecting negative book equity, $15.85B of long-term debt, and an unproven standalone margin structure) applied to $7.89 of next-FY consensus EPS = $181.47. Cross-checked against cash flow: a normalized FCF of roughly $1.8-2.2B on ~$18B of revenue at a 3.5-4.0% FCF yield implies $170-$200 per share, bracketing the same figure.